您当前的位置：
首页 >
文章列表页 >
Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway
更新时间：2025-01-24

    • Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway

    • “The latest research has found that the modified Guishen Pill effectively improves ovarian function and has anti-inflammatory effects in polycystic ovary syndrome rats by inhibiting the MAPK/NF - κ B pathway.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 5, Pages: 86-94(2025)

    • DOI：10.13422/j.cnki.syfjx.20241842    

      CLC： R285;R242;R271

    • Received：26 August 2024，

      Accepted：06 November 2024，

      Published Online：07 November 2024，

      Published：05 March 2025

    移动端阅览

  • TIAN Jiayu,QIN Wenyi,YANG Juan,et al.Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):86-94. DOI： 10.13422/j.cnki.syfjx.20241842.

  •  
  •  

0

Views

20

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mechanism of Modified Guishenwan in Regulating AMPK/Akt/Nrf2 Pathway to Improve Glucose and Lipid Metabolism and Oxidative Stress in Polycystic Ovary Syndrome Rats
Research of Influence on Inflammation of Xieheyin on PCOS-IR Mice Based on Intestinal Mucosal Barrier and TLR4/NF-κB/NLRP3 Pathway
Zhenzhu Tiaozhi Capsules Reduce Renal Lipid Deposition and Inflammation in Mouse Model of Diabetic Kidney Disease via SCAP-SREBP-1c/NLRP3 Signaling Pathway

Related Author

QIN Wenyi
YANG Juan
Xue-fei XU
En-li WANG
Tian-ye YANG
Jing-chun YAO
Xin GONG
Wen-yue CHEN

Related Institution

Affiliated Hospital of Nanjing University of Chinese Medicine
State Key Laboratory of Generic Manufacture Technology of Traditional Chinese Medicine
Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine， Guangdong Pharmaceutical University
Hunan University of Chinese Medicine
Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases， Hunan University of Chinese Medicine
0